Lundin Gold Inc. (TSX:LUG)

Verve Therapeutics Revenue

Lundin Gold had revenue of $452.88M USD in the quarter ending June 30, 2025, with 50.24% growth. This brings the company's revenue in the last twelve months to $1.47B, up 58.50% year-over-year. In the year 2024, Lundin Gold had annual revenue of $1.19B with 32.19% growth.

• Revenue (ttm): $1.47B
• Revenue Growth: +58.50%
• P/S Ratio: 8.89
• Revenue / Employee: $7.48M
• Employees: 197
• Market Cap: 17.87B

Revenue Chart

* This company reports financials in USD.

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	1.19B	290.53M	32.19%
Dec 31, 2023	902.52M	86.85M	10.65%
Dec 31, 2022	815.67M	82.34M	11.23%
Dec 31, 2021	733.33M	375.17M	104.75%
Dec 31, 2020	358.16M	-	-